Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): appeal announcement
The Institute have received one joint appeal from the below organisations, however this appeal has been rejected.
- Sarcoma UK
- GIST Support UK
- Rarer Cancers Foundation
- Association of Cancer Physicians (ACP)
- The Institute of Cancer Research (ICR)
- NCRI (NCRI) Sarcoma Clinical Studies Group
- Royal College of Physicians (RCP)
- Royal College of Radiologists (RCR)
- Joint Collegiate Council for Oncology (JCCO)
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): appeal received
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): initial scrutiny
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to scrutiny
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scrutiny letter
This page was last updated: 24 November 2010